These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17571959)

  • 1. The potential role of intrinsic hypoxia markers as prognostic variables in cancer.
    Moon EJ; Brizel DM; Chi JT; Dewhirst MW
    Antioxid Redox Signal; 2007 Aug; 9(8):1237-94. PubMed ID: 17571959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs in cancer: from bench to bedside.
    Cortez MA; Ivan C; Zhou P; Wu X; Ivan M; Calin GA
    Adv Cancer Res; 2010; 108():113-57. PubMed ID: 21034967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.
    Mizukami Y; Kohgo Y; Chung DC
    Clin Cancer Res; 2007 Oct; 13(19):5670-4. PubMed ID: 17908955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Inducible Factors: Master Regulators of Cancer Progression.
    Schito L; Semenza GL
    Trends Cancer; 2016 Dec; 2(12):758-770. PubMed ID: 28741521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous hypoxia markers: case not proven!
    Mayer A; Höckel M; Vaupel P
    Adv Exp Med Biol; 2008; 614():127-36. PubMed ID: 18290322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hypoxia in cancer therapy by regulating the tumor microenvironment.
    Jing X; Yang F; Shao C; Wei K; Xie M; Shen H; Shu Y
    Mol Cancer; 2019 Nov; 18(1):157. PubMed ID: 31711497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIFs, angiogenesis, and cancer.
    Yang Y; Sun M; Wang L; Jiao B
    J Cell Biochem; 2013 May; 114(5):967-74. PubMed ID: 23225225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia in cancer: significance and impact on clinical outcome.
    Vaupel P; Mayer A
    Cancer Metastasis Rev; 2007 Jun; 26(2):225-39. PubMed ID: 17440684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia in head and neck cancer: how much, how important?
    Janssen HL; Haustermans KM; Balm AJ; Begg AC
    Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microRNA component of the hypoxic response.
    Kulshreshtha R; Davuluri RV; Calin GA; Ivan M
    Cell Death Differ; 2008 Apr; 15(4):667-71. PubMed ID: 18219318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α in colorectal carcinoma: review of the literature.
    Ioannou M; Paraskeva E; Baxevanidou K; Simos G; Papamichali R; Papacharalambous C; Samara M; Koukoulis G
    J BUON; 2015; 20(3):680-9. PubMed ID: 26214618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of supervised gene signatures of early hypoxia on patient survival.
    Seigneuric R; Starmans MH; Fung G; Krishnapuram B; Nuyten DS; van Erk A; Magagnin MG; Rouschop KM; Krishnan S; Rao RB; Evelo CT; Begg AC; Wouters BG; Lambin P
    Radiother Oncol; 2007 Jun; 83(3):374-82. PubMed ID: 17532074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.
    Tatum JL; Kelloff GJ; Gillies RJ; Arbeit JM; Brown JM; Chao KS; Chapman JD; Eckelman WC; Fyles AW; Giaccia AJ; Hill RP; Koch CJ; Krishna MC; Krohn KA; Lewis JS; Mason RP; Melillo G; Padhani AR; Powis G; Rajendran JG; Reba R; Robinson SP; Semenza GL; Swartz HM; Vaupel P; Yang D; Croft B; Hoffman J; Liu G; Stone H; Sullivan D
    Int J Radiat Biol; 2006 Oct; 82(10):699-757. PubMed ID: 17118889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic potential of the pre-therapeutic tumor oxygenation status.
    Vaupel P
    Adv Exp Med Biol; 2009; 645():241-6. PubMed ID: 19227477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
    Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
    Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypoxic tumor microenvironment and gene expression.
    Leo C; Giaccia AJ; Denko NC
    Semin Radiat Oncol; 2004 Jul; 14(3):207-14. PubMed ID: 15254863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.
    Pantuck AJ; Zeng G; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2003 Oct; 9(13):4641-52. PubMed ID: 14581333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.